Skip to Content

View Additional Section Content

HCRN GI14-198- Phase II Randomized, Double-Blind Study of mFOLFIRINOX plus 26 Ramucirumab versus mFOLFIRINOX plus placebo in Advanced Pancreatic Cancer Patients.

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/record/NCT02581215?term=hcrn+gi14-198&rank=1

Clinical Trial Categories

  • Pancreatic Cancer
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM